CDMO maker of APIs, intermediates and crop-protection chemicals for global pharma and agrochem innovators.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 792 | 909 | 1.0k | 1.1k | 1.2k | 1.2k | 1.2k | 1.2k |
| Borrowings | 646 | 610 | 675 | 748 | 818 | 765 | 683 | 684 |
| Other Liabilities | 306 | 370 | 470 | 504 | 482 | 502 | 472 | 483 |
| Total Liabilities | 1.8k | 1.9k | 2.2k | 2.4k | 2.5k | 2.5k | 2.3k | 2.4k |
| AssetsFixed Assets | 735 | 713 | 879 | 948 | 1.1k | 1.4k | 1.3k | 1.3k |
| CWIP | 161 | 254 | 295 | 412 | 414 | 121 | 134 | 94 |
| Investments | 1 | 1 | 11 | 5 | 5 | 10 | 10 | 10 |
| Other Assets | 871 | 946 | 1.0k | 1.0k | 997 | 1.0k | 865 | 928 |
| Total Assets | 1.8k | 1.9k | 2.2k | 2.4k | 2.5k | 2.5k | 2.3k | 2.4k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 186 | 285 | 229 | 294 | 315 | 187 | 280 | 302 |
| Cash from Investing | -125 | -164 | -156 | -284 | -292 | -174 | -136 | -145 |
| Cash from Financing | -55 | -101 | -97 | -6 | -8 | -27 | -144 | -160 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 57 | 127 | 71 | 21 | 13 | -17 | 144 | 154 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
HIKAL · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.